Management of Paget's Disease of the Calcaneum

Joel Humphrey; Anum Pervez; Roland Walker; Ali Abbasian; Sam Singh

doi:10.1053/j.jfas.2016.10.006

Management of Paget's Disease of the Calcaneum

J Foot Ankle Surg. 2017 Mar-Apr;56(2):401-403. doi: 10.1053/j.jfas.2016.10.006. Epub 2017 Jan 6.

Authors

Joel Humphrey¹, Anum Pervez², Roland Walker³, Ali Abbasian³, Sam Singh³

Affiliations

¹ Orthopaedic Registrar, Orthopaedic Department, Guys' and St Thomas' National Health Services Foundation Trust, London, United Kingdom. Electronic address: drjoelhumphrey@aol.com.
² Foundation Year Trainee, Orthopaedic Department, Guys' and St Thomas' National Health Services Foundation Trust, London, United Kingdom.
³ Consultant Orthopaedic Surgeon, Orthopaedic Department, Guys' and St Thomas' National Health Services Foundation Trust, London, United Kingdom.

PMID: 28089128
DOI: 10.1053/j.jfas.2016.10.006

Abstract

The calcaneum is not the most common site for Paget's disease of bone, with only a few reports of monostotic involvement. We present 2 cases of Paget's disease of bone affecting the calcaneus, present an overview of the published data, and describe our management of these interesting cases.

Keywords: Paget's disease; SQSTM1 gene; bisphosphonate; blade of grass; calcaneus; flame edge; osteoblast.

Publication types

Case Reports

MeSH terms

Aged
Alkaline Phosphatase / blood
Bone Density Conservation Agents / therapeutic use
Calcaneus / diagnostic imaging*
Diphosphonates / therapeutic use
Female
Humans
Imidazoles / therapeutic use
Osteitis Deformans / diagnostic imaging*
Osteitis Deformans / therapy*
Radiography
Risedronic Acid / therapeutic use
Shoes
Tomography, Emission-Computed, Single-Photon
Zoledronic Acid

Substances

Bone Density Conservation Agents
Diphosphonates
Imidazoles
Zoledronic Acid
Alkaline Phosphatase
Risedronic Acid